(HealthDay)—U.S. children in need of a kidney transplant are faring better now than a couple of decades ago, but there is still plenty of room for improvement, a new study finds.
7 hours ago
not rated yet | 0
Scientists from the University of Sheffield have developed a novel antibody-based therapy which targets the progression of life threating kidney fibrosis.
Feb 14, 2014
5 / 5 (1) | 0